(RTTNews) - Dyne Therapeutics, Inc. (DYN), Tuesday announced that the U.S. Food and Drug Administration has granted Fast Track designation for DYNE-101 for the treatment of myotonic dystrophy type 1, ...

INDIANAPOLIS (WISH) — Previous research on the effects of COVID-19 found it linked to heart attack, heart failure, brain fog, diabetes, and gastrointestinal issues. But now researchers have ...

HONG KONG, Jan 28 (Reuters) - China is aiming to beef up physical education in schools, making it core to the curriculum rather than a secondary subject, authorities said as they push for a more ...

(RTTNews) - Dyne Therapeutics, Inc. (DYN), Tuesday announced that the U.S. Food and Drug Administration has granted Fast Track designation for DYNE-101 for the treatment of myotonic dystrophy type ...

Much has been written about the demise of physical media. Long considered the measure of technological progress in audiovisual and computing fields, the 2000s saw this metric seemingly rendered ...

It may be, she added, that weekly therapy sessions are simply not scalable to a broad population, and the field should explore light-touch alternatives, like single-session interventions and ...

A scientific statement regarding CPET interpretation in patients with congenital HD across their lifespan has been published by the AHA.

They also learn how to reduce the physical distress of anxiety and how to approach the situations that trigger their symptoms or general discomfort. Therapy is usually conducted in a series of 12 ...

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism (HI) Ersodetug continues to advance ...

New partnership hopes to give BSS patients more options for treatment. Viralgen and Axovia Therapeutics are partnering to develop and manufacture a gene therapy for the treatment of retinal dystrophy ...